Published in Recent Prog Horm Res on January 01, 1957
A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem (1952) 18.27
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem (1960) 8.08
The physiological disposition and metabolic fate of hydrocortisone in man. J Clin Invest (1955) 6.74
TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. J Biol Chem (1964) 5.40
Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. J Biol Chem (1954) 5.08
A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med (1957) 5.04
The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. J Biol Chem (1955) 4.29
Identification and assay of serotonin in brain. J Pharmacol Exp Ther (1956) 4.17
The chemical estimation of tyrosine and tyramine. J Biol Chem (1952) 4.09
The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther (1957) 3.99
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 3.60
A chemical method for the determination of free choline in plasma. J Biol Chem (1953) 3.57
ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART. J Pharmacol Exp Ther (1965) 3.45
The estimation of 5-hydroxytryptamine (serotonin) in biological tissues. J Biol Chem (1955) 3.28
Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med (1960) 3.26
On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther (1959) 3.16
Some physico-chemical factors in drug action. J Pharm Pharmacol (1957) 3.13
Enzymatic hydroxylation of aromatic compounds. Arch Biochem Biophys (1956) 3.09
The fate of antipyrine in man. J Pharmacol Exp Ther (1950) 3.05
Serotonin release as a possible mechanism of reserpine action. Science (1955) 3.03
The direct determination of phosphatidyl ethanolamine and phosphatidyl serine in plasma and red blood cells. J Biol Chem (1953) 2.98
Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science (1960) 2.87
A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Am J Med (1956) 2.84
BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther (1965) 2.82
Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem (1954) 2.78
INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS. J Pharmacol Exp Ther (1965) 2.77
A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci (1957) 2.71
Aromatic L-amino acid decarboxylase. J Biol Chem (1962) 2.70
Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther (1958) 2.62
Formation of indole-3-acetic acid and tryptamine in animals: a method for estimation of indole-3-acetic acid in tissues. J Biol Chem (1959) 2.57
The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J Pharmacol Exp Ther (1950) 2.54
The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. J Pharmacol Exp Ther (1957) 2.46
The fate of pentobarbital in man and dog and a method for its estimation in biological material. J Pharmacol Exp Ther (1953) 2.38
Identification and chemical assay of norepinephrine in brain and other tissues. J Pharmacol Exp Ther (1958) 2.37
Enzymatic metabolism of drugs and other foreign compounds. Annu Rev Biochem (1958) 2.36
Incorporation of C14-labeled amino acids into actinomycin and protein by Streptomyces antibioticus. J Biol Chem (1963) 2.29
Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther (1956) 2.26
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther (1957) 2.20
Detoxication of drugs and other foreign compounds by liver microsomes. Science (1955) 2.20
Effect of iproniazid on serotonin metabolism in vivo. J Pharmacol Exp Ther (1957) 2.16
Estimation of intracellular water in man. Am J Physiol (1950) 2.14
The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain. J Neurochem (1957) 2.13
Evidence that serotonin has a role in brain function. Science (1955) 2.13
Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J Pharmacol Exp Ther (1960) 2.10
The fate of thiopental in man and a method for its estimation in biological material. J Pharmacol Exp Ther (1950) 2.10
A RAPID AND SIMPLE RADIOASSAY FOR TYROSINE HYDROXYLASE ACTIVITY. Anal Biochem (1964) 2.09
The enzymatic conversion of phenylalanine to tyrosine. J Biol Chem (1952) 2.09
A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine. J Biol Chem (1960) 2.08
Isolation and properties of crystalline cobamide coenzymes containing benzimidazole or 5, 6-dimethylbenzimidazole. J Biol Chem (1960) 2.07
Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science (1955) 1.99
Assay, purification, and properties of the adenylocobamide coenzyme. J Biol Chem (1960) 1.94
CONVERSION OF PROLINE TO COLLAGEN HYDROXYPROLINE IN A CELL-FREE SYSTEM FROM CHICK EMBRYO. J Biol Chem (1963) 1.89
Absorption of drugs from the stomach. I. The rat. J Pharmacol Exp Ther (1957) 1.86
Absorption of drugs from the stomach. II. The human. J Pharmacol Exp Ther (1957) 1.85
Fluorescence characteristics of 5-hydroxytryptamine (serotonin). Science (1955) 1.84
Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate. J Pharmacol Exp Ther (1954) 1.78
Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines. J Biol Chem (1955) 1.77
The metabolic fate of phenylbutazone (butazolidin) in man. J Pharmacol Exp Ther (1955) 1.76
Isolation of gamma-aminobutyrylhistidine (homocarnosine) from brain. J Biol Chem (1961) 1.76
Increase in tissue serotonin following administration of its precursor 5-hydroxytryptophan. J Biol Chem (1957) 1.74
Preparation of C14 uniformly labeled fructose by means of photosynthesis and paper chromatography. Science (1949) 1.74
The purification and properties of beta-methylaspartase. J Biol Chem (1959) 1.70
ENZYMATIC HYDROXYLATION OF PROLINE IN MICROSOMAL POLYPEPTIDE LEADING TO FORMATION OF COLLAGEN. Proc Natl Acad Sci U S A (1965) 1.70
Release of inorganic tripolyphosphate from adenosine triphosphate during vitamin B-12 coenzyme biosynthesis. J Biol Chem (1963) 1.69
Further observations on patients with malignant carcinoid. Am J Med (1957) 1.69
5-Hydroxytryptophan decarboxylase: preparation and properties. J Biol Chem (1954) 1.66
Assay of L-phenylalanine as phenylethylamine after enzymatic decarboxylation; application to isotopic studies. J Biol Chem (1953) 1.65
The hydroxylation of phenylalanine and antipyrine in phenylpyruvic oligophrenia. J Biol Chem (1953) 1.64
Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther (1959) 1.63
The physiological disposition and metabolic fate of cortisone in man. J Clin Invest (1957) 1.62